Emergent Biosolutions ( (EBS) ) has provided an announcement.
Emergent BioSolutions Inc. secured a new $100 million asset-backed revolving loan facility, showcasing their strengthened financial position and supporting their multi-year transformation plan. The agreement with Wells Fargo Bank offers flexible terms and extended maturity until September 2029, with provisions for early maturity based on other indebtedness. This move follows Emergent’s recent refinancing and demonstrates their ongoing commitment to strategic goals and sustainable growth.
See more data about EBS stock on TipRanks’ Stock Analysis page.
